Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 3, 2008, Pages 240-249

  Rodriguez, Fausto J ^a,b   Perry, Arie ^c   Gutmann, David H ^c   O'Neill, Brian Patrick ^b   Leonard, Jeffrey ^c   Bryant, Sandra ^b   Giannini, Caterina ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytoma; Brain tumor; Central nervous system; Glioma; Neurofibromatosis; Pilocytic astrocytoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; DESMOPLASTIC INFANTILE GANGLIOGLIOMA; DIFFUSELY INFILTRATING ASTROCYTOMA; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MITOSIS; NEUROFIBROMATOSIS; PILOCYTIC ASTROCYTOMA; PILOMYXOID ASTROCYTOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR DIAGNOSIS; TUMOR VOLUME; VISUAL SYSTEM; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; GLIOMA; HUMANS; INFANT; MALE; MIDDLE AGED; MITOTIC INDEX; NEUROFIBROMATOSIS 1; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 41649113333     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318165eb75     Document Type: Article

References (23)

1. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57
2. Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press, 2007
3. Stern J, DiGiacinto GV, Housepian EM. Neurofibromatosis and optic glioma: Clinical and morphological correlations. Neurosurgery 1979;4:524-28
4. Gutmann DH, Rasmussen SA, Wolkenstein P, et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 2002;59:759-61
5. Leonard JR, Perry A, Rubin JB, et al. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology 2006;67:1509-12
6. Parsa CF, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic gliomas: Thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001;119:516-29
7. Thiagalingam S, Flaherty M, Billson F, et al. Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients. Ophthalmology 2004;111:568-77
8. Zeid JL, Charrow J, Sandu M, et al. Orbital optic nerve gliomas in children with neurofibromatosis type 1. J AAPOS 2006;10:534-39
9. King A, Listernick R, Charrow J, et al. Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome. Am J Med Genet A 2003;122:95-99
10. Guillamo JS, Creange A, Kalifa C, et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients. Brain 2003;126:152-60
11. Vinchon M, Soto-Ares G, Ruchoux MM, et al. Cerebellar gliomas in children with NF1: Pathology and surgery. Childs Nerv Syst 2000;16:417-20
12. Riffaud L, Vinchon M, Ragragui O, et al. Hemispheric cerebral gliomas in children with NF1: Arguments for a long-term follow-up. Childs Nerv Syst 2002;18:43-47
13. Rodriguez HA, Berthrong M. Multiple primary intracranial tumors in von Recklinghausen's neurofibromatosis. Arch Neurol 1966;14:467-75
14. Ilgren E, Kinnier-Wilson L, Stiller C. Gliomas in neurofibromatosis: A series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas. Pathol Annu 1985;20:331-58
15. Listernick R, Ferner RE, Liu GT, et al. Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations. Ann Neurol 2007;61:189-98
16. Cummings TJ, Provenzale JM, Hunter SB, et al. Gliomas of the optic nerve: Histological, immunohistochemical (MIB-1 and p53), and MRI analysis. Acta Neuropathol (Berl) 2000;99:563-70
17. Daginakatte GC, Gutmann DH. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 2007;16:1098-1112
18. Warrington NM, Woerner BM, Daginakatte GC, et al. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1. Cancer Res 2007;67:8588-95
19. Tihan T, Fisher PG, Kepner JL, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999;58:1061-68
20. Khanani MF, Hawkins C, Shroff M, et al. Pilomyxoid astrocytoma in a patient with neurofibromatosis. Pediatr Blood Cancer 2006;46:377-80
21. Parizel PM, Martin JJ, Van Vyve M, et al. Cerebral ganglioglioma and neurofibromatosis type I. Case report and review of the literature. Neuroradiology 1991;33:357-59
22. Fedi M, Anne Mitchell L, Kalnins RM, et al. Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study. J Clin Neurosci 2004;11:745-47
23. VandenBerg SR, May EE, Rubinstein LJ, et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg 1987;66:58-71